Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This study aims to investigate the efficacy and safety of depemokimab compared with mepolizumab in adults with relapsing or refractory EGPA receiving SoC therapy.
Epistemonikos ID: b8c48b6af755e6081db7a7511a34b3d44810be35
First added on: Oct 02, 2023